Boeing Wins $20 Billion Navy Fighter Contract, Giving Defense Business a New Long-Term Program

SEATTLE, September 30, 2026, ZEX PR WIRE — Boeing has secured a development contract worth $20 billion to build the U.S. Navy’s next-generation stealth fighter, giving the aerospace manufacturer another major military aviation program and adding a significant new contract to its defense portfolio. The Pentagon selected Boeing over Northrop Grumman for Read more

September 30, 2026|

China’s Factory Activity Returns to Growth as AI Boom Supports Industrial Demand

SINGAPORE, September 30, 2026, ZEX PR WIRE — China’s manufacturing sector returned to expansion in September, with official data showing factory activity improving after two consecutive months of contraction. The rebound comes as easing weather disruptions helped factories resume operations while continued global demand linked to artificial intelligence provided additional support to Read more

September 30, 2026|

Asia Share Sales Surge as AI Boom Drives Record Capital Raising Pipeline

HONG KONG, September 30, 2026, ZEX PR WIRE — The capital raising boom reflects the scale of investment now flowing into semiconductors, data centers and power infrastructure as companies position themselves around the rapid expansion of artificial intelligence. The development comes despite a more challenging global financial environment, with bond yields elevated Read more

September 30, 2026|

Global Bonds Face Worst September in Years as Higher Yields Test Stock Market Resilience

SINGAPORE, September 30, 2026, ZEX PR WIRE — Global bonds remained under pressure on Wednesday as investors assessed the impact of higher energy costs, deteriorating fiscal conditions and expectations that interest rates could remain elevated for longer. The benchmark 10 year U.S. Treasury yield was around 5.24% in Asian trading and was Read more

September 30, 2026|

CE-Ventures Backs Aptadir Therapeutics in €40 Million Seed Round, One of Europe’s Largest in Biotech

Aptadir raises €40 million in Italy’s largest biotech seed round and one of the largest in Europe Financing will advance a novel class of RNA inhibitor-based therapeutics, including lead candidate CAP1-FMR1 for Fragile X Syndrome Investment broadens CE-Ventures’ life sciences portfolio with an RNA therapeutics platform Dubai, United Arab Emirates, Read more

September 30, 2026|

Oura Delays U.S. IPO as Market Volatility Tests Appetite for New Listings

SAN FRANCISCO, Calif., September 29, 2026, ZEX PR WIRE — Oura Health announced Tuesday that it was postponing its planned U.S. IPO because of market uncertainty. The decision comes as global financial markets face renewed volatility, with rising Treasury yields and higher energy prices making conditions more challenging for companies preparing to Read more

September 29, 2026|
Go to Top